Olema Pharmaceuticals inc (NAS:OLMA)
$ 11.43 +0.29 (+2.6%) Market Cap: 998.38 Mil Enterprise Value: 496.99 Mil PE Ratio: 0 PB Ratio: 2.08 GF Score: 33/100

Olema Pharmaceuticals Inc at Citi Oncology Leadership Summit (Virtual) Transcript

Feb 19, 2026 / 06:00 PM GMT
Release Date Price: $23.81 (+6.25%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OLMA.OQ - Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc at Citi Oncology Leadership Summit (Virtual)
Feb 19, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right. Welcome everyone, to the next session. This is day two of CITI's Virtual Oncology Summit. I'm Miguel Naimovitz, biotech analyst here at City in New York. Remember, if you have questions, for our speaker, who is, Sean Bone, the CEO of Alima, and we'll start the conversation in a moment. If you have questions for him, just email me and I will, relay them over. Sure. So, Sean, thank you so much. Welcome. I appreciate the time. A lot going on in the world of breast cancer, as you know. A lot to discuss. But before we get to all of that stuff, maybe just, for the, for those a little bit less familiar with Alima, give us the high-level overview of the company. Tell us a little about Palzestrin.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot